SCHEMBL30963530

SCHEMBL30963530

Cc1ccnn1-c1nncs1

nearest known ligand 0.35

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
KDM5B Q9UGL1 1/20 0.34
KDM4E B2RXH2 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
TDP1 Q9NUW8 1/20 0.31
KMT2A Q03164 1/20 0.30
OXTR P30559 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30963447 0.69 ALDH1A1 (0.39) KDM5AKDM4CKDM5BKDM4EALDH1A1
SCHEMBL30963570 0.69 POLB (0.37) KDM5AKDM4CKDM5B
SCHEMBL16198079 0.67 GPX4 (0.44) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL967912 0.62 ALDH1A1 (0.44) KDM5BKDM4EALDH1A1GAAHPGD
SCHEMBL23130273 0.61 CYP2C9 (0.49) KDM5AKDM4CKDM5BALDH1A1HPGD
SCHEMBL15779574 0.59 OXTR (0.48) KDM5AKDM4CKDM5BKDM4EALDH1A1
SCHEMBL18725081 0.59 KDM5A (0.37) KDM5AKDM4CKDM5BALDH1A1HSD17B10
SCHEMBL15299343 0.59 NPC1 (0.41) KDM5AKDM4CKDM5BKDM4EALDH1A1
SCHEMBL19453172 0.59 OXTR (0.48) ALDH1A1GAAHSD17B10KMT2AOXTR
SCHEMBL9464682 0.59 KDM4E (0.43) KDM4EALDH1A1GAAHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4638446-A1 THIADIAZOLE DERIVATIVES AS INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF Ventus Therapeutics U.S., Inc. (US) 2025-10-29 EP disclosed
WO-2024137607-A1 THIADIAZOLE DERIVATIVES AS INHIBITORS OF CYCLIC GMP-AMP SYNTHASE AND USES THEREOF VENTUS THERAPEUTICS U.S., INC. (US) 2024-06-27 WO disclosed